On the other hand, no αsyn abnormalities could be observed in ATP13A2-null mice [30] and AAV-mediated overexpression of human ATP13A2 was not protective in an αsyn-based rat model of PD [31]. This evidence concerns the gene ATP13A2 and Parkinson disease.